Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-07-09 @ 4:22 AM
Study NCT ID:
NCT07359066
Status:
RECRUITING
Last Update Posted:
2026-02-05
First Post:
2025-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors
Sponsor:
Shanghai SciBrunch Therapeutics Co., Ltd.
Organization: